Egyptian Restaurant Serves Unconventional Sandwiches

Tourists are seen next to a meal made by Saqqara residents, who
sell food to improve their living conditions in thier village, in
Giza, Egypt, on April 27, 2021. REUTERS/Shokry Hussien
Tourists are seen next to a meal made by Saqqara residents, who sell food to improve their living conditions in thier village, in Giza, Egypt, on April 27, 2021. REUTERS/Shokry Hussien
TT

Egyptian Restaurant Serves Unconventional Sandwiches

Tourists are seen next to a meal made by Saqqara residents, who
sell food to improve their living conditions in thier village, in
Giza, Egypt, on April 27, 2021. REUTERS/Shokry Hussien
Tourists are seen next to a meal made by Saqqara residents, who sell food to improve their living conditions in thier village, in Giza, Egypt, on April 27, 2021. REUTERS/Shokry Hussien

In a step toward innovation and breaking the traditional, an Egyptian restaurant is serving unconventional “sandwiches”, offering its customers the chance to try diverse tastes including the meat of pigeons, ostriches, and ducks.

Located in the Nasr City, eastern Cairo, the Zouzou Restaurant, which is set to open a new branch in the October City, promotes its special sandwiches, their ingredients, and how they are prepared with videos on its official Facebook page.

The restaurant serves duck and turkey shawarma prepared in the same traditional way with onion, tomato, pepper, hot pepper, spices, and various sauces, but served in local bread. Shawarma choices are many and satisfy all tastes with new flavors, including pastrami, sausage, and traditional meat shawarma.

The “Hawawshi” sandwich are served with a twist as well; the best kind is “Hawawshi Zouzou”, a mix of spinach, mushroom, and smoked beef. There are also the pastrami hawawshi, hamburger, and local sausage. Turkey or liver hawawshi are also available in different sizes, including the ‘mini’ hawawshi of pastrami, liver, or sausage stuffing accompanied with different kinds of cheese such as mozzarella.

The idea of the restaurant consists of serving unfamiliar sandwiches made of meats that customers are used to eat in different ways.

“The restaurant is trying to change the old typical view of protein consumption by serving it in the form of “sandwich”. Eating pigeons or ducks doesn’t require a table and many utensils anymore. Now, you can eat it in a new, easy way,” Amro al-Soubki, manager of the Zouzou restaurant, told Asharq Al-Awsat.

For more innovation, the restaurant has reintroduced some of its most popular dishes with different “stuffing” choices, like the turkey shawarma sandwich seasoned with coriander and pineapple sauce; or the duck shawarma soaked in sweet orange juice, dill, honey mustard sauce, and tahini.

Alongside the non-traditional sandwiches, the Zouzou restaurant is experimenting with Tajines. It serves ostriches tajin, which according to the chef, “helps reduce blood cholesterol, and address many digestif problems.” “Ostrich meat is highly demanded because they are cooked fresh, right after the slaughter,” he added.

Tawouk has a share of innovation too. At the Zouzou restaurant, Tawouk is made of duck, or turkey soaked in yogurt, herbs, and spices. Among the other unfamiliar plates served at Zouzou are the ostrich steak and “mumbar” bites (mumbar are ‘animal intestines’ cleaned and stuffed with rice, spices, and tomato juice, then cut and fried).

“Serving protein in a sandwich has opened the door for more innovations that we will launch soon, including the ‘veal akawi’. Although ostrich meat is expensive and not so popular in Egypt, it’s among the most demanded plates, alongside hawawshi and shawarma,” said Soubki.

In addition to the popular, traditional shawarma, the restaurant also serves the pastrami shawarma with sliced olive and cheese mix, as well as shawarma of sausage, smoked beef, or mushroom and other types of vegetables like spinach.

Egyptian are used to pigeons stuffed with rice or grits, but at Zouzou, it’s served as “Kofta”, made of boneless pigeon meat mixed with onions and spices, and served as small rings, or with rice.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”